Qube Research & Technologies Ltd

Position in NKTR — Nektar Therapeutics

CIK 1729829 LONDON, X0

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,111,671

-$18,997,395 QoQ

Shares Held

130,521

-66.6% QoQ

Ownership

0.382%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#46

of 240 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. NKTR ranks #50 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,111,671	130,521	-66.6%	Shares	Sole	2026-08-14
2026-03-31	$28,109,066	390,675	+20.6%	Shares	Sole	2026-05-15
2025-12-31	$13,695,126	323,915	+8050.9%	Shares	Sole	2026-02-17
2025-09-30	$226,120	3,974	-94.0%	Shares	Sole	2025-11-14
2024-12-31	$61,155	65,759	+303.3%	Shares	Sole	2025-02-14
2024-06-30	$20,216	16,304	-62.8%	Shares	Sole	2024-08-14
2024-03-31	$40,785	43,855	+69.1%	Shares	Sole	2024-05-14
2023-12-31	$14,527	25,942	-54.9%	Shares	Sole	2024-02-13
2023-09-30	$34,516	57,528	-84.8%	Shares	Sole	2023-11-13
2023-06-30	$219,470	378,398	+595.3%	Shares	Sole	2023-08-14
2022-12-31	$122,989	54,420	+22.4%	Shares	Sole	2023-02-14
2022-06-30	$168,989	44,471	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.